Expression levels of miR-96 were upregulated in MSA with a concomitant decrease in its targets genes, the solute carrier protein family members SLC1A1 and SLC6A6, in both MSA patients and a transgenic mouse model of MSA. This evidence concerns the gene SLC6A6 and multiple system atrophy.